Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clemizole HCl in Lennox-Gastaut Syndrome
NCT05066217Phase 3Recruiting
- Sponsor
- Epygenix Therapeutics
- Start
- Apr 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of clemizole in Lennox-Gastaut syndrome (LGS), sponsored by Epygenix Therapeutics. Started Apr 2025; status: recruiting.
02
Drugs
clemizole
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on NCT05066217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05066217.